Follow Us:

social twitter box white 32 social facebook box blue 32social linkedin box blue 32ISN Blog

Thursday, 05 October 2017 10:22

Learning lessons from Hong Kong’s ‘PD First Policy’  Featured

By 
Rate this item
(1 Vote)

Between 2.3 and 7.1 million people die annually from End-Stage Kidney Disease (ESKD) due to a lack of access to dialysis. As a high-income country with expertise in peritoneal dialysis (PD), Hong Kong has a lot of practical experience to offer its neighboring low- and middle-income countries in tackling this growing issue.

I highlighted the importance of global access to integrated ESKD care at the Hong Kong Society of Nephrology's recent Annual Scientific Meeting. 

Hong Kong can have a substantial impact on the goal of increasing global access to integrated ESKD care, building more capacity in low- and middle-income countries. PD is a safe and effective form of dialysis. Above all, it is cheaper than hemodialysis (HD), making it a more suitable option to care for patients in low- and middle-income countries. 

BBN 9278

At the front, from left to right: Philip Li (President of Asian Pacific Society of Nephrology), David Harris (President of International Society of Nephrology),  Richard Yu (Senior Advisor of Hong Kong Society of Nephrology), Susan Quaggin (American Society of Nephrology Councillor) and Sydney Tang (President Hong Kong Society of Nephrology).

With its PD First Policy, Hong Kong has a greater percentage of dialysis patients on PD than any other country, and excellent outcomes. The PD First Policy was established in 1985. In 30 years, through this policy, Hong Kong has built up a successful model of practice and enhanced support to patients. 

According to published figures, switching to PD is a more cost-effective way to manage the growing number of ESKD patients as HD is 3.6 times more expensive in Hong Kong. In 2013, 76% of dialysis patients were treated with PD, which is the highest percentage in the world. 

Read more about the PD First Policy in The Lancet Kidney Campaign update written by Asian Pacific Society of Nephrology President Philip Kam-Tao Li and entitled: Peritoneal Dialysis: perspectives from Hong Kong, Asia Pacific and beyond. CLICK HERE.

Read 2463 times Last modified on Tuesday, 10 October 2017 10:39
David Harris

David Harris is ISN President and Professor of Medicine at The University of Sydney, Director of Nephrology and Dialysis in the Western Sydney Renal Service, and Director of the Renal Failure Laboratory in the Centre for Transplantation and Renal Research, Westmead Institute for Medical Research.

WCN 2019

WCN2019

ISN Frontiers 2018

ISN FRONTIERS 2018

Global Operations Center

Rue des Fabriques 1
1000 Brussels, Belgium
Tel: +32 2 808 04 20
Fax: +32 2 808 4454
Email contact

               

Americas Operations Center

340 North Avenue 3rd Floor
Cranford, NJ 07016-2496, United States
Tel: +1 567 248 9703
Fax: +1 908 272 7101
Email contact